Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
Closure of the acquisitions is anticipated in the first half of next year, contingent on customary closing conditions and regulatory clearances. The total purchase price will be paid from Fulgent's cash on hand. The addition of Bako and StrataDx is anticipated to bolster Fulgent's lab services business with the inclusion of new products and services, widening its national client base as well as sales team, and increasing its team of pathologists. Bako offers a comprehensive testing menu that includes anatomic pathology, molecular genetic testing, and peripheral neuropathy immuno-histochemical testing. StrataDx provides dermatopathology testing services and is Clinical Laboratory Improvement Amendments (CLIA)-certified and State of Massachusetts-licenced. Fulgent is said to have invested in AI and digital pathology, including the Eziopath image management system launch. The adoption of these technologies is expected to enhance the capacity, turnaround times and quality of
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDxBusiness Wire
- Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]Seeking Alpha
- Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Fulgent Genetics (NASDAQ:FLGT) had its price target raised by analysts at Piper Sandler from $21.00 to $30.00. They now have a "neutral" rating on the stock.MarketBeat
FLGT
Earnings
- 11/7/25 - Beat
FLGT
Analyst Actions
- 11/14/25 - Raymond James Financial, Inc.
FLGT
Sec Filings
- 12/22/25 - Form 8-K
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- FLGT's page on the SEC website